Various genes that were significantly changed, such as CD79B, CLDN2, SPP1 and IGHG3 (Fig. 7d and Supplementary Fig. 10b) were the marker genes of the identified cell types or sub-populations, probably owing to the high heterogeneity in cellular compositions across the tumor samples, as observed above. The gene discussed is CLDN2; the disease is neoplasm.